๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), h...
Status
Completed
Location
UZ Brussel
Start Date
2011-02
Trial ID
NCT01302496
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine wit...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-04
Trial ID
NCT02385669
Treatments Being Tested
RATIONALE: Aldesleukin may stimulate the white blood cells to kill tumor ce...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2008-06
Trial ID
NCT00726739
Treatments Being Tested
This research study is studying the drugs called NeoVax (a new type of pers...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2022-01-03
Trial ID
NCT04930783
Treatments Being Tested
Goal: To characterize the cellular events that occur in vivo after vaccinat...
Status
Completed
Location
University of Virginia
Start Date
2004-06
Trial ID
NCT00912574
Treatments Being Tested
The aim of the study is to show if vaccination with autologous dendritic ce...
Status
Completed
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Start Date
2004-09
Trial ID
NCT00197912
Treatments Being Tested
The purpose of this research study is to see if the combination of HSPPC-96...
Status
Withdrawn
Location
UTHealth Memorial Hermann Cancer Center
Start Date
2015-12
Trial ID
NCT02452281
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
This randomized phase II trial is studying how well giving vaccine therapy ...
Status
Terminated
Location
National Cancer Institute Surgery Branch
Start Date
2005-11
Trial ID
NCT00303836
Current therapeutic approaches available for patients with advanced-stage m...
Status
Completed
Location
Hillman Cancer Center
Start Date
2014-05-16
Trial ID
NCT01876212
Treatments Being Tested